Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation

Br J Haematol. 1994 Mar;86(3):651-3. doi: 10.1111/j.1365-2141.1994.tb04801.x.

Abstract

We report on a male who received a bone-marrow allograft from his HLA identical sister for acute myelogenous leukaemia. After transplantation, the patient suffered from refractoriness to the transfusions of HLA-matched platelets and a strong platelet-specific antibody, anti-HPA-2b, of IgG1 subclass was demonstrated in the patient's serum. In the serum of the bone-marrow donor a weak IgG1 anti-HPA-2b was demonstrated. IgG allotyping of the patient and donor showed identical results. We could not determine the origin of the anti-HPA-2b, although we hypothesize that the anti-HPA-2b was produced by immunocompetent donor lymphocytes infused with the suspension of bone-marrow cells.

Publication types

  • Case Reports

MeSH terms

  • Antigens, Human Platelet / immunology*
  • Blood Platelets / immunology*
  • Bone Marrow Transplantation / immunology*
  • Humans
  • Immunoglobulin G / blood*
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Middle Aged
  • Platelet Count
  • Platelet Transfusion*
  • Transplantation, Homologous

Substances

  • Antigens, Human Platelet
  • Immunoglobulin G